Celgene Corp (NASDAQ:CELG)

82.41
Delayed Data
As of Oct 19
 -0.54 / -0.65%
Today’s Change
74.13
Today|||52-Week Range
137.45
-21.03%
Year-to-Date

Today’s Trading

Previous close82.95
Today’s open83.00
Day’s range82.20 - 84.17
Volume3,905,486
Average volume (3 months)5,133,410
Market cap$58.0B
Data as of 4:00pm ET, 10/19/2018

Growth & Valuation

Earnings growth (last year)+46.18%
Earnings growth (this year)+18.08%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+17.40%
P/E ratio22.6
Price/Sales6.58
Price/Book9.04

Competitors

 Today’s
change
Today’s
% change
SHPGShire-1.97-1.11%
AGNAllergan+0.64+0.34%
VRTXVertex Pharmaceutica...-3.21-1.79%
ZTSZoetis Inc-0.36-0.39%
Data as of 4:15pm ET, 10/19/2018

Financials

Next reporting dateOctober 25, 2018
EPS forecast (this quarter)$2.23
Annual revenue (last year)$12.8B
Annual profit (last year)$2.9B
Net profit margin22.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
COO
Mark J. Alles
Chief Financial Officer &
Executive Vice President
David V. Elkins
Corporate headquarters
Summit, New Jersey

Forecasts